1 not yet recruiting, 1 terminated. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Not yet recruiting 1, Terminated 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Acute Heart Failure (AHF): new trials by email Literature Review of Acute Heart Failure (AHF) trials Research Report on Acute Heart Failure (AHF)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure Furosemide 40 Milligrams., Hydrochlorothiazide (HCTZ) 25 milligrams., Acetazolamide 250 milligrams. - Acute Heart Failure (AHF), Congestive Heart Failure Acute | Phase 2 / Phase 3 | Not yet recruiting | Hospital de Clinicas de Porto Alegre | 128 | 2026-03-23 | 2026-03-18 |
| Effect of Serelaxin Versus Standard of Care in Acute Heart Failure (AHF) Patients Serelaxin, Standard of Care - Acute Heart Failure (AHF) | Phase 3 | Terminated | Novartis Pharmaceuticals | 2666 | 2014-01-31 | 2019-03-22 |
Heart Failure (1) · Renal Insufficiency (1)
Cardiovascular Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Heart Diseases (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Hydrochlorothiazide (1) · Standard of Care (1) · dapagliflozin (1) · serelaxin protein, human (1)
Hospital de Clinicas de Porto Alegre (1) · Novartis Pharmaceuticals (1)
Austria (1) · Belgium (1) · Brazil (1) · Bulgaria (1) · Croatia (1) · Czechia (1) · Estonia (1) · Finland (1) · France (1) · Germany (1) · Greece (1) · Hungary (1) · Iceland (1) · Italy (1) · Latvia (1)